| Drug Type Small molecule drug | 
| Synonyms INCB-177054, INCB177054 | 
| Target | 
| Action inhibitors | 
| Mechanism DGKA inhibitors(diacylglycerol kinase alpha inhibitors), DGKζ inhibitors(diacylglycerol kinase zeta inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePhase 1/2 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 2 | United States  | 30 Jun 2025 | |
| Metastatic Solid Tumor | Phase 2 | United States  | 30 Jun 2025 | 





